Calibration of PET/CT scanners for multicenter studies on differentiated thyroid cancer with 124I

被引:0
作者
Jakob W. Kist
Manfred van der Vlies
Otto S. Hoekstra
Henri N. J. M. Greuter
Bart de Keizer
Marcel P. M. Stokkel
Wouter V. Vogel
Marc C. Huisman
Arthur van Lingen
机构
[1] Netherlands Cancer Institute,Department of Nuclear Medicine
[2] Groene Hart Ziekenhuis,Department of Diagnostics
[3] VU University Medical Center,Department of Radiology and Nuclear Medicine
[4] University Medical Center Utrecht,Department of Nuclear Medicine
来源
EJNMMI Research | / 6卷
关键词
Calibration; Multicenter; Quantification; PET/CT; Iodine-124; Differentiated thyroid cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [11] 124I PET/CT in the pretherapeutic staging of differentiated thyroid carcinoma: comparison with posttherapy 131I SPECT/CT
    de Pont, Cecile
    Halders, Servais
    Bucerius, Jan
    Mottaghy, Felix
    Brans, Boudewijn
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (05) : 693 - 700
  • [12] Effects of Rosiglitazone on Radioiodine Negative and Progressive Differentiated Thyroid Carcinoma as Assessed by 124I PET/CT Imaging
    Rosenbaum-Krumme, Sandra Julia
    Freudenberg, Lutz Stefan
    Jentzen, Walter
    Bockisch, Andreas
    Nagarajah, James
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (03) : E47 - E52
  • [13] Effectiveness of [124I]-PET/CT and [18F]-FDG-PET/CT for Localizing Recurrence in Patients with Differentiated Thyroid Carcinoma
    Lee, Jandee
    Nah, Kuk Young
    Kim, Ra Mi
    Oh, Yeon-Ju
    An, Young-Sil
    Yoon, Joon-Kee
    An, Gwang Il
    Choi, Tae Hyun
    Cheon, Gi Jeong
    Soh, Euy-Young
    Chung, Woong Youn
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (09) : 1019 - 1026
  • [14] Value of 124I-PET/CT in staging of patients with differentiated thyroid cancer
    Freudenberg, LS
    Antoch, G
    Jentzen, W
    Pink, R
    Knust, J
    Görges, R
    Müller, SP
    Bockisch, A
    Debatin, JF
    Brandau, W
    EUROPEAN RADIOLOGY, 2004, 14 (11) : 2092 - 2098
  • [15] Value of 124I-PET/CT in staging of patients with differentiated thyroid cancer
    L. S. Freudenberg
    G. Antoch
    W. Jentzen
    R. Pink
    J. Knust
    R. Görges
    S. P. Müller
    A. Bockisch
    J. F. Debatin
    W. Brandau
    European Radiology, 2004, 14 : 2092 - 2098
  • [16] Quantitative Comparison of 124I PET/CT and 131I SPECT/CT Detectability
    Beijst, Casper
    Kist, Jakob W.
    Elschot, Mattijs
    Viergever, Max A.
    Hoekstra, Otto S.
    de Keizer, Bart
    de Jong, Hugo W. A. M.
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (01) : 103 - 108
  • [17] Initial Clinical Investigation of [18F]Tetrafluoroborate PET/CT in Comparison to [124I]Iodine PET/CT for Imaging Thyroid Cancer
    Samnick, Samuel
    Al-Momani, Ehab
    Schmid, Jan-Stefan
    Mottok, Anja
    Buck, Andreas K.
    Lapa, Constantin
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (03) : 162 - 167
  • [18] Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in 124I PET/CT-Based Dosimetry for 131I Therapy of Metastatic Differentiated Thyroid Cancer
    Plyku, Donika
    Hobbs, Robert F.
    Huang, Kevin
    Atkins, Frank
    Garcia, Carlos
    Sgouros, George
    Van Nostrand, Douglas
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (07) : 1146 - 1154
  • [19] The diagnostic value of 124I-PET in patients with differentiated thyroid cancer
    Phan, Ha T. T.
    Jager, Pieter L.
    Paans, Anne M. J.
    Plukker, John T. M.
    Sturkenboom, M. G. G.
    Sluiter, W. J.
    Wolffenbuttel, Bruce H. R.
    Dierckx, Rudi A. J. O.
    Links, Thera P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (05) : 958 - 965
  • [20] The diagnostic value of 124I-PET in patients with differentiated thyroid cancer
    Ha T. T. Phan
    Pieter L. Jager
    Anne M. J. Paans
    John T. M. Plukker
    M. G. G. Sturkenboom
    W. J. Sluiter
    Bruce H. R. Wolffenbuttel
    Rudi A. J. O. Dierckx
    Thera P. Links
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 958 - 965